Prognostic biomarkers of renal cell carcinoma: Recent advances

被引：4

作者：

Kitamura, Hiroshi ^{[1
]}

Tsukamoto, Taiji ^{[1
]}

机构：

[1] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan

来源：

INDIAN JOURNAL OF UROLOGY | 2008年 / 24卷 / 01期

关键词：

Biomarker; prognosis; renal cell carcinoma;

D O I：

10.4103/0970-1591.38596

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Recent advances in understanding the characteristics of renal cell carcinoma (RCC) have brought to our attention many prognostic markers that affect and predict the survival outcome of patients with the disease. For the moment, however, patients with RCC have not received any benefit from such markers. If a patient is diagnosed as Thigh risk" by using such prognostic markers, there is no promising systemic therapy available. In this review we mainly focus on biomarkers of RC( that can be applied for therapeutic use reported in recent publications. Several issues and limitations in the reported studies are also highlighted and discussed. Developing biomarkers from the viewpoint of therapeutic application will lead to improvement of the prognosis of RCC patients.

引用

页码：10 / 15

页数：6

共 40 条

[1] The molecular basis and potential role of survivin in cancer diagnosis and therapy [J].

Altieri, DC .

TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :542-547

[2] Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer [J].

Atkins, M ;

Regan, M ;

McDermott, D ;

Mier, J ;

Stanbridge, E ;

Youmans, A ;

Febbo, P ;

Upton, M ;

Lechpammer, M ;

Signoretti, S .

CLINICAL CANCER RESEARCH, 2005, 11 (10) :3714-3721

[3] Serum angiogenic activity: Diagnostic relevance in renal cell carcinoma [J].

Beecken, WD ;

Bentas, W ;

Glienke, W ;

Linneweber, J ;

Jonas, D ;

Binder, J ;

Kramer, W .

EUROPEAN UROLOGY, 2002, 42 (04) :364-369

[4] Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells [J].

Bleumer, Ivar ;

Tiemessen, Dorien M. ;

Oosterwijk-Wakka, Jeannette C. ;

Voller, Maureen C. W. ;

De Weijer, Kim ;

Mulders, Peter F. A. ;

Oosterwijk, Egbert .

JOURNAL OF IMMUNOTHERAPY, 2007, 30 (01) :116-122

[5]

Bui MHT, 2003, CLIN CANCER RES, V9, P802

[6] Expression of survivin in renal cell carcinomas: Association with pathologic features and clinical outcome [J].

Byun, Seok-Soo ;

Yeo, Woon Geol ;

Lee, Sang Eun ;

Lee, Eunsik .

UROLOGY, 2007, 69 (01) :34-37

[7] Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas [J].

Cózar, J ;

Canton, J ;

Tallada, M ;

Concha, A ;

Cabrera, T ;

Garrido, F ;

Osuna, FRC .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (09) :858-866

[8] Impact of immune parameters on long-term survival in metastatic renal cell carcinoma [J].

Donskov, F ;

von der Maase, H .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :1997-2005

[9]

Edgren M, 2001, ANTICANCER RES, V21, P1423

[10] Hypoxia-inducible factor-1α-expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer [J].

Generali, Daniele ;

Berruti, Alfredo ;

Brizzi, Maria P. ;

Campo, Leticia ;

Bonardi, Simone ;

Wigfield, Simon ;

Bersiga, Alessandra ;

Allevi, Giovanni ;

Milani, Manuela ;

Aguggini, Sergio ;

Gandolfi, Valeria ;

Dogliotti, Luigi ;

Bottini, Alberto ;

Harris, Adrian L. ;

Fox, Stephen B. .

CLINICAL CANCER RESEARCH, 2006, 12 (15) :4562-4568

← 1 2 3 4 →